Article Details
Retrieved on: 2024-02-26 21:48:08
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Reuters) - FibroGen Inc said on Monday it is regaining rights to the anemia drug, roxadustat, from AstraZeneca after the companies mutually ...
Article found on: whbl.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here